Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.

S Bourgoin, F Artaud, J Bockaert

    Naunyn-Schmiedeberg'S Archives of Pharmacology
    |May 5, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.

    NPJ Parkinson's disease·2024
    Same author

    Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study.

    Parkinsonism & related disorders·2020
    Same author

    Modeling individual and relative accuracy of screening tools in geriatric oncology.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2015
    Same author

    The nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity.

    Translational psychiatry·2012
    Same author

    8-OH-DPAT regulates the amplitude and the phase of LH surge in ovariectomized steroid-primed rats.

    Endocrine·2010
    Same journal

    Retraction Note: Comprehensive in vivo and in silico approaches to explore the hepatoprotective activity of poncirin against paracetamol toxicity.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    Same journal

    Multi-method statistical signal aggregation with machine learning for severity classification of neonatal adverse drug reactions.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    Same journal

    Herbacetin as a natural GPR35 agonist for allergic asthma relief via dual regulation of PI3K/Akt/mTOR and MAPK signaling.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    Same journal

    Exploring the potential mechanism of GABA in the treatment of abdominal aortic aneurysm through network pharmacology and experimental validation.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    Same journal

    Multi-layer network biology combined with single-cell evidence reveals core regulatory nodes in atherosclerotic plaques and potential drug-targeting directions.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    Same journal

    Formulation, evaluation, and optimisation of soft chewable lozenges using Box-Behnken design for the treatment of schizophrenia.

    Naunyn-Schmiedeberg's archives of pharmacology·2026
    See all related articles

    Metergoline blocks serotonin (5-HT) receptors in the rat brain, affecting 5-HT turnover differently than other antagonists. This suggests distinct receptor types and regulatory mechanisms in the brain.

    Area of Science:

    • Neuropharmacology
    • Serotonin receptor research

    Background:

    • Metergoline is a known peripheral serotonin (5-HT) antagonist.
    • Investigating its central nervous system effects is crucial for understanding serotonergic pathways.

    Purpose of the Study:

    • To investigate the central 5-HT receptor blocking effects of metergoline in the rat brain.
    • To analyze the impact of metergoline on 5-HT turnover in vivo.

    Main Methods:

    • In vitro assays: Inhibition of 3-H-5-HT binding and 5-HT-stimulated adenylate cyclase activity.
    • In vivo studies: Measurement of 3-H-5-HT binding capacity and 5-HT turnover after metergoline administration.

    Main Results:

    • Metergoline demonstrated potent inhibition of 3-H-5-HT binding and adenylate cyclase activity in vitro.

    Related Experiment Videos

  • In vivo, metergoline significantly reduced 3-H-5-HT binding capacity in rat brain synaptosomal membranes.
  • Unexpectedly, metergoline decreased 5-HT utilization and synthesis, unlike other 5-HT antagonists.

    • Conclusions:

    • Metergoline acts as a potent blocker of specific serotonergic receptors in the rat brain.
    • The observed decrease in 5-HT turnover suggests a unique mechanism of action, possibly involving positive feedback regulation.
    • These findings indicate the existence of multiple serotonin receptor subtypes with differential responses to antagonists.